Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas

Journal of Pathology

Volumn 205, Issue 3, 2005, Pages 349-358

  Nakamura, Etsuko ^a   Sugihara, Hiroyuki ^a   Bamba, Masamichi ^a   Hattori, Takanori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

catenin; E cadherin; Signet ring cells; Tumour invasion; Undifferentiated type gastric carcinoma

Indexed keywords

BETA CATENIN; UVOMORULIN; WNT PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL DIFFERENTIATION; CLINICAL ARTICLE; DOWN REGULATION; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; STOMACH MUCOSA; TUMOR DIFFERENTIATION; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; BETA CATENIN; CADHERINS; CARCINOMA, SIGNET RING CELL; CELL DIFFERENTIATION; CYTOSKELETAL PROTEINS; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

EID: 13844281020     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1718     Document Type: Article

References (39)

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenic regulator. Science 1991; 251: 1451-1455.
2. Shiozaki H, Tahara H, Oka H, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991; 139: 17-23.
3. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994; 1198: 11-26.
4. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-339.
5. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392 402-405.
6. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nature Genet 2000; 25: 16-17.
7. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001; 20: 1525-1528.
8. Tamura G, Sato K, Akiyama S, et al. Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 2001; 81: 593-598.
9. Ozawa M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cystoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 1990; 87: 4246-4250.
10. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci 1993; 17: (Suppl): 155-158.
11. Morin PJ, Sparks AB, Korinek V, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275: 1787-1790.
12. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790-1792.
13. Berx G, Nollet P, van Roy F. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun 1998; 6: 171-184.
14. Park WS, Oh RR, Park JY, et al. Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer. Cancer Res 1999; 59: 4257-4260.
15. Clements WM, Wang J, Sarnaik A, et al. β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002; 62: 3503-3506.
16. Cotran RS, Kumar V, Collins T (eds). Robbins Pathologic Basis of Disease (6th edn). Saunders: Philadelphia, 1999; 302-305.
17. Engbring JA, Kleinman HK. The basement membrane matrix in malignancy. J Pathol 2003; 200: 465-470.
18. Moll R, Mitze M, Frixen UH, Brichmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 143: 1731-1742.
19. Lehr HA, Folpe A, Yaziji H, Kommoss F, Gown AM. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol 2000; 114: 190-196.
20. Sugihara H. Proliferation and differentiation of human signet ring cell carcinoma in gastric mucosa: fine structural basis of the morphogenesis of 'layered structure'. J Kyoto Pref Univ Med 1984; 93: 591-605 (in Japanese with English abstract).
21. Sugihara H, Hattori T, Fukuda M, Fujita S. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch A 1987; 411: 117-127.
22. Watanabe H, Jass JR, Sobin LH. Histological Typing of Oesophageal and Gastric Tumours (2nd edn). Springer: Berlin, 1990; 76-78.
23. Carneiro F. Classification of gastric carcinomas. Curr Diagn Pathol 1997; 4: 51-59.
24. Peng D-F, Sugihara H, Mukaisho K, Ling Z-Q, Hattori T. Genetic lineage of poorly differentiated gastric carcinoma with tubular component analyzed by comparative genomic hybridization. J Pathol 2004; 203: 884-495.
25. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma (1st English edn). Kanehara: Tokyo, 1995.
26. Bukholm IK, Nasland JM, Borrensen-Dale AL. Re-expression of E-cadherin, α-catenin and β-catenin, but not γ-catenin in metastatic tissue from breast cancer patients. J Pathol 2000; 190: 15-19.
27. Liu J, Ikeguchi M, Nakamura S, Kaibara N. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. J Exp Clin Cancer Res 2002; 21: 65-71.
28. Kozuki T, Yao T, Nakamura S, Matsumoto T, Tsuneyoshi M. Differences in p53 and cadherin-catenin complex expression between histological subtypes in diffusely infiltrating gastric carcinioma. Histopathology 2002; 41: 56-64.
29. Sugimoto N, Imoto I, Fukuda Y, et al. IQGAP1, a negative regulator of cell-cell adhesion, is upregulated by gene amplification at 15q26 in gastric cancers cell lines HSC39 and 40A. J Hum Genet 2001; 46: 21-25.
30. Fukata M, Nakagawa M, Itoh N, et al. Involvement of IQGAP1, an effector of Rac1 and Cdc42 GTPases, in cell-cell dissociation during cell scattering. Mol Cell Biol 2001; 21: 2165-2183.
31. Shimao Y, Nabeshima K, Inoue T, Koono M. Complex formation of IQGAP1 with E-cadherin/catenin during cohort migration of carcinoma cells. Its possible association with localized release from cell-cell adhesion. Virchows Arch 2002; 441: 124-132.
32. Maeno Y, Noroi S, Nagashima H, et al. Alpha-catenin-deficient F9 cells differentiate into signet ring cells. Am J Pathol 1999; 154: 1323-1328.
33. Davies G, Jiang WG, Mason MD. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 2001; 7: 3289-3297.
34. Li G, Schaider H, Satyamoorthy K, Hanakawa Y, Hashimoto K, Herlyn M. Downregulation of E-cadherin and desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene 2001; 20: 8125-8135.
35. Sasaki CY, Lin H, Morin PJ, Longo DL. Truncation of the extracellular region abrogates cell contact but retains the growth-suppressive activity of E-cadherin. Cancer Res 2000; 60 7057-7065.
36. Kirchner T, Brabletz T. Patterning and nuclear β-catenin expression in the colonic adenoma-carcinoma sequence. Am J Pathol 2000; 157: 1113-1121.
37. Yasui W, Kuniyasu H, Akama Y, et al. Expression of E-cadherin, α- and β-catenins in human gastric carcinomas: correlation with histology and tumor progression. Oncol Rep 1995; 2: 111-117.
38. Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1 and Twist in gastric cancer. Am J Pathol 2002; 161: 1881-1891.
39. Becker K-F, Kremmer E, Eulitz M, et al. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies. J Pathol 2002; 197: 567-574.